Stockscreener 앱 받기
10.04
0.20%
-0.005
Immatics N V 주식(IMTX)의 최신 뉴스
Immatics N.V. (NASDAQ:IMTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Immatics (IMTX) Updates on Promising IMA203CD8 Cell Therapy Tria - GuruFocus
Immatics presents IMA203CD8 PRAME cell therapy data at ESMO-IO Congress - TipRanks
Immatics Reveals Promising Results from IMA203CD8 Phase 1a Trial - TipRanks
Immatics Announces Promising Phase 1a Dose Escalation Results for IMA203CD8, a Second-Generation PRAME Cell Therapy for Advanced Solid Tumors - Quiver Quantitative
Immatics (NASDAQ: IMTX) reports 46% ORR for IMA203CD8 in Phase 1a PRAME solid tumors - Stock Titan
Is Immatics NV a good long term investmentMorning Star Patterns & Breakthrough Stock Performance - earlytimes.in
A look into Immatics N.V (IMTX)’s deeper side - setenews.com
Immatics Completes $116.5 Million Share Offering to Boost R&D - TipRanks
Immatics completes $116.5 million share offering to boost R&D - MSN
Immatics announces offering of 12.5M ordinary shares - MSN
How Investors Are Reacting To Immatics (IMTX) $125 Million Follow-On Equity Offering - simplywall.st
Finance Watch: Biotech Investors Take FDA Turmoil In Stride - Citeline News & Insights
Immatics (NASDAQ:IMTX) Trading Up 8.9%Time to Buy? - MarketBeat
Immatics Down Nearly 15%, on Pace for Largest Percent Decrease Since October 2024 -- Data Talk - 富途牛牛
Immatics announces $125 million underwritten offering - marketscreener.com
Immatics Announces $125 Million Underwritten Offering - TradingView — Track All Markets
Perhaps timely catching Immatics N.V (IMTX) would be a good idea - Setenews
Immatics Plans $125 Million Stock Offering - marketscreener.com
Immatics (Nasdaq: IMTX) files share offering, reports 46% ORR and 9.2‑month mDOR - Stock Titan
Immatics N.V. Announces Agreement to Sell 12.5 Million Ordinary Shares in Underwritten Offering - Quiver Quantitative
Immatics (NASDAQ: IMTX) to sell 12,500,000 shares at $10.00 in underwritten offering - Stock Titan
Revenues Not Telling The Story For Immatics N.V. (NASDAQ:IMTX) After Shares Rise 28% - simplywall.st
Immatics N.V.'s (NASDAQ:IMTX) 28% Price Boost Is Out Of Tune With Revenues - 富途牛牛
Immatics (NASDAQ:IMTX) Sets New 12-Month HighHere's What Happened - MarketBeat
How Immatics N.V. (4A3) stock compares with tech leaders2025 Bull vs Bear & Smart Allocation Stock Reports - Newser
Price-Driven Insight from (IMTX) for Rule-Based Strategy - news.stocktradersdaily.com
Is Immatics N.V. (4A3) stock included in top ETFsGold Moves & Short-Term Trading Alerts - Newser
Why pension funds invest in Immatics N.V. (4A3) stockWeekly Profit Recap & Weekly Watchlist of Top Performers - Newser
What dividend safety rating applies to Immatics N.V. (4A3) stockJuly 2025 WrapUp & Community Trade Idea Sharing Platform - Newser
Why Immatics N.V. (4A3) stock could rally stronglyJuly 2025 Recap & AI Enhanced Trading Alerts - Newser
Immatics (IMTX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Why Immatics N.V. Equity Warrant stock could outperform in 2025Weekly Earnings Recap & AI Enhanced Trading Signals - Newser
Is Immatics N.V. (4A3) stock a buy before new product rolloutIPO Watch & Free Fast Entry Momentum Trade Alerts - Newser
Why Immatics N.V. stock is considered a top pick2025 Risk Factors & Precise Buy Zone Identification - BỘ NỘI VỤ
Why Immatics N.V. stock is rated strong buy2025 Growth vs Value & High Win Rate Trade Tips - BỘ NỘI VỤ
Immatics Reports Q3 2025 Financial Results and Business Update - MSN
FY2025 EPS Estimates for Immatics Lowered by Chardan Capital - MarketBeat
How Rising Losses in the Latest Results Will Impact Immatics (IMTX) Investors - simplywall.st
Is Immatics N.V. (4A3) stock a top dividend aristocrat candidateJuly 2025 Selloffs & Weekly Chart Analysis and Guides - BỘ NỘI VỤ
Immatics N.V. Reports Q3 2025 Financial Results and Progress - MSN
How sustainable is Immatics N.V. stock dividend payoutGDP Growth & Weekly High Momentum Picks - BỘ NỘI VỤ
Views of Wall Street’s Leading Experts on Immatics N.V - Setenews
Chardan Capital Reaffirms Buy Rating for Immatics (NASDAQ:IMTX) - MarketBeat
Chardan Capital Maintains Immatics N.V. (IMTX) Buy Recommendation - Nasdaq
IMTX: Chardan Capital Maintains Buy Rating with $25 Target | IMT - GuruFocus
(IMTX) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
Immatics FY2025 EPS Estimate Boosted by Cantor Fitzgerald - MarketBeat
Immatics FY2025 EPS Estimate Lifted by Cantor Fitzgerald - Defense World
FY2025 EPS Estimates for Immatics Boosted by Leerink Partnrs - MarketBeat
Will Immatics N.V. (4A3) stock return to pre crash levelsIPO Watch & Risk Controlled Swing Alerts - newser.com
Heatmap analysis for Immatics N.V. and competitorsJuly 2025 Volume & AI Driven Price Forecasts - newser.com
What macro factors could drive Immatics N.V. (4A3) stock higherBear Alert & Low Drawdown Momentum Ideas - newser.com
Immatics FY2025 EPS Estimate Increased by Leerink Partnrs - Defense World
Immatics (NASDAQ:IMTX) Given New $23.00 Price Target at Mizuho - MarketBeat
0.56%
1.23%
자본화:
|
볼륨(24시간):